Lyell Immunopharma (LYEL) Q1 2025 Earnings

12MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.71
-0.53
-0.35
-0.17

Details

Expected EPS
-0.17
Actual EPS
-0.705
Surprise EPS
-0.53
Surprise Percent
+314.71%

Description

Lyell Immunopharma (LYEL) has reported earnings of -0.705 per share for Q1 2025.

0 Comments

Share your thoughts